This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Trochon-Joseph, V. Articles by Lu, H. Search for Related Content PubMed PubMed Citation Articles by Trochon-Joseph, V. Articles by Lu, H.

Evidence of Antiangiogenic and Antimetastatic Activities of the Recombinant Disintegrin Domain of Metargidin

¹ Inserm U553, Hôpital Saint-Louis, Paris; ² Bioalliance Pharma SA, Paris; ³ Unité Mixte de Recherche 8121, Centre National de la Recherche Scientifique, Institut Gustave-Roussy, Villejuif; ⁴ DIFEMA, Faculté de Médecine et Pharmacie de Rouen, Rouen; and ⁵ Laboratoires Sainte-Marie and EMI 353 INSERM, Hôtel-Dieu, Paris, France

Metargidin, a transmembrane protein of the adamalysin family, and integrins, e.g., 5ß1 and v, are preferentially expressed on endothelial cells on angiogenesis. Furthermore, metargidin interacts with these integrins via its disintegrin domain. In this study, recombinant human disintegrin domain (RDD) was produced in Escherichia coli by subcloning its cDNA into the pGEX-2T vector, and the effect of purified RDD on different steps of angiogenesis was evaluated. At concentrations of 2–10 µg/ml, RDD exhibited inhibitory activities in a variety of in vitro functional assays, including endothelial cell proliferation and adhesion on the integrin substrates fibronectin, vitronectin, and fibrinogen. RDD (10 µg/ml) totally abrogated endothelial cell migration and blocked most capillary formation in a three-dimensional fibrin gel. To test RDD efficacy in vivo, the RDD gene inserted into pBi vector containing a tetracycline-inducible promoter was electrotransferred into nude mouse muscle. RDD was successfully synthesized by muscle cells in vivo as shown by immunolabeling and Western blotting. In addition, 78% less MDA-MB-231 tumor growth, associated with strong inhibition of tumor angiogenesis, was observed in athymic mice bearing electrotransferred RDD. Moreover, in the presence of RDD, 74% fewer B16F10 melanoma lung metastases were found in C57BL/6 mice. Taken together, these results identified this RDD as a potent intrinsic inhibitor of angiogenesis, tumor growth, and metastasis, making it a promising tool for use in anticancer treatment.

This article has been cited by other articles:

				B. Xie, J. Shen, A. Dong, M. Swaim, S. F. Hackett, L. Wyder, S. Worpenberg, S. Barbieri, and P. A. Campochiaro An Adam15 amplification loop promotes vascular endothelial growth factor-induced ocular neovascularization FASEB J, August 1, 2008; 22(8): 2775 - 2783. [Abstract] [Full Text] [PDF]

				A. J. Najy, K. C. Day, and M. L. Day The Ectodomain Shedding of E-cadherin by ADAM15 Supports ErbB Receptor Activation J. Biol. Chem., June 27, 2008; 283(26): 18393 - 18401. [Abstract] [Full Text] [PDF]

				L. Charrier-Hisamuddin, C. L. Laboisse, and D. Merlin ADAM-15: a metalloprotease that mediates inflammation FASEB J, March 1, 2008; 22(3): 641 - 653. [Abstract] [Full Text] [PDF]

				J. L. Zhong, Z. Poghosyan, C. J. Pennington, X. Scott, M. M. Handsley, A. Warn, J. Gavrilovic, K. Honert, A. Kruger, P. N. Span, et al. Distinct Functions of Natural ADAM-15 Cytoplasmic Domain Variants in Human Mammary Carcinoma Mol. Cancer Res., March 1, 2008; 6(3): 383 - 394. [Abstract] [Full Text] [PDF]

				A. J. Najy, K. C. Day, and M. L. Day ADAM15 Supports Prostate Cancer Metastasis by Modulating Tumor Cell-Endothelial Cell Interaction Cancer Res., February 15, 2008; 68(4): 1092 - 1099. [Abstract] [Full Text] [PDF]

				R. Korn, S. Rohrig, S. Schulze-Kremer, and U. Brinkmann Common denominator procedure: a novel approach to gene-expression data mining for identification of phenotype-specific genes Bioinformatics, June 1, 2005; 21(11): 2766 - 2772. [Abstract] [Full Text] [PDF]

				L. Charrier, Y. Yan, A. Driss, C. L. Laboisse, S. V. Sitaraman, and D. Merlin ADAM-15 inhibits wound healing in human intestinal epithelial cell monolayers Am J Physiol Gastrointest Liver Physiol, February 1, 2005; 288(2): G346 - G353. [Abstract] [Full Text] [PDF]